Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Infectious Disease Specialists (EU)(?)

Council Members in this Study Group: 342

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
HLA screening for ABV hypersensitivity reaction | 07-28-2008
Author: GLG Expert Contributor

After the extensive studies published (Mallal et al), it becomes mandatory to perform a genetic HLA screening before starting abacavir-containing antiretroviral associations. Problems are recognizable in these points: - laboratories are not capable to front an exaggerated request of HLA typing; - ad-hoc...

To consider the possible role of the new NNRTI etravirine in the treatment of HIV infection | 02-27-2008
Author: GLG Expert Contributor

Etravirine is a novel and very promising NNRTI since it has not cross-resistance with the existing NNRTIs (efavirenz and nevirapine), and also encompasses excellent efficacy, convenience, and a good tolerability.

A new NNRTI strong,safe and respectful of other similar drugs next use | 02-11-2008
Author: GLG Expert Contributor

HIV therapy must be the strongest and the most safe therapy ; NNRTI are the key drugs for this kind of therapy. When you,doctor,begin a  naive HIV therapy, you must think that your patient should be treated for a very long time , maybe for a whole life period ; it'simportant...

Very Good News For HIV Infected Individuals. Sandro Vento, MD. Azienda Ospedaliera di Cosenza, Italy | 12-20-2007
Author: GLG Expert Contributor

Atripla is a fixed combination in a single pill of three excellent antiretroviral drugs with very good pharmacokinetics profile and fairly good tolerability. It will have a considerable impact on compliance as it can be taken once daily. If compliance will be as good as predictable, the chances that...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Academic Institution*
  • Non-Academic Community Hospital or Clinic
  • Government/Military Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Division Head
  • Physician - Director
  • Professor
  • Director
  • Physician - Department Chair

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-05T05:45:18.353